Survey 2004 | Survey 2008 | |||||||
---|---|---|---|---|---|---|---|---|
Original product companies n (%)a | Generic product companies n (%) | Total n (%)b | P-value | Original product companies n (%) | Generic product companies n (%) | Total n (%) | P-value | |
Has generic substitution influenced the research and development of new pharmaceutical products in Finland in your company?* | 0.161 | 0.154 | ||||||
No | 8 (57) | 2 (67) | 10 (59) | 8 (67) | 3 (75) | 11 (69) | ||
Research and development has decreased | 5 (36) | - | 5 (29) | 4 (33) | - | 4 (25) | ||
Research and development has increased | - | 1 (33) | 1 (6) | - | - | - | ||
Some other impactc | 2 (14) | - | 2 (12) | - | 1 (25) | 1 (6) | ||
Total | 14 (107) | 3 (100) | 17 (106) | 12 (100) | 4 (100) | 16 (100) |